Stout Jay S
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1702969. Latest Form 4 filed Oct 23, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Immunovant, Inc.IMVT | Chief Technology Officer, Officer | 1 | 2026-10-21 | 2026-10-21 |
Transactions: 1
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Immunovant, Inc.Chief Technology Officer, Officer | Sale | 2,595 | $28.94 | $75.1k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 11:45 ET. Listed shows no prices and gives no investment advice.